Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

<< Previous

Bullboard Posts

Next >>

Post by CaptainConnon Feb 25, 2021 12:54pm

125 Views

Post# 32659022

Weak

Putting in a bearish engulfing today. Has failed at 60 twice now so, expect more pain in the short term. Technicals are weak. I am long the stock and excited for what happens in the sector over the next few years. The broader market getting beat up is not helpful. Glta

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1